HEALTH● LOW2h ago · Sep 17, 2026, 3:46 PM
Novo Nordisk (NVO) and Eli Lilly (LLY)’s Weight-Loss Drugs Still Work at Smaller Doses, Study Finds
Yahoo Finance · global
A study indicates that weight-loss drugs from Novo Nordisk and Eli Lilly remain effective even at smaller doses. This finding has implications for medical treatment and pharmaceutical development.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH18m agoThe misdirected narrative around Nigeria’s HIV response: Are we ready to change it?, By Adaeze OrehPremium TimesHEALTH24m agoChile First in South America to Eliminate Dog-Transmitted RabiesHuman ProgressHEALTH44m agoTakeda Pharmaceutical (TAK) Gets Priority Review. Can Zasocitinib Win in Psoriasis?Yahoo FinanceHEALTH1h agoBoiling lemon peel, ginger, and cinnamon: what it's for and why it's recommendedClarín